• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS ENDOVASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS ENDOVASCULAR STENT GRAFT Back to Search Results
Catalog Number UNK FLUENCYPLUS ENDO STNT GRFT
Device Problems Material Erosion (1214); Fracture (1260); Migration or Expulsion of Device (1395)
Patient Problems No Known Impact Or Consequence To Patient (2692); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 10/09/2012
Event Type  Injury  
Manufacturer Narrative
As no lot number was provided, a device history record review could not be performed.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported through an article in the journal of vascular surgery titled "complications of endovascular grafts in the treatment of pseudoaneurysms and stenoses in arteriovenous access", that an unknown number of stent grafts was used and that during a 44 month period, several patients presented with complications which included migration, fracture and erosion.The number of devices that were involved is unknown and the deficiencies were not linked to a specific device; therefore, one complaint was conservatively opened to capture the events.Detailed patient outcomes have not been reported.
 
Manufacturer Narrative
As no specific lot number was provided, a device history record review could not be performed.As no sample was returned and the images that were part of the journal article could not clarify the relationship between a specific product and failure mode, the reported event could not be reproduced.As per the information provided in the article, no specific failure mode related to a specific product was reported.The use of an endovascular stent graft for treatment of an aneurysm is considered an off-label use as the device is indicated for the treatment of stenosis at the venous anastomosis of eptfe or other synthetic arteriovenous (av) access grafts, not for use in the treatment of pseudoaneurysms.It is unknown whether the relevant products were used for pseudoaneurysm treatment.On the basis of the limited information available, no further investigation could be performed and no root cause could be determined.The ifu supplied with this device states that complications and adverse events associated with use of the fluency plus endovascular stent graft may include the usual complications associated with endovascular stent and stent graft placement and dialysis shunt revisions.The ifu also states that the safety and effectiveness of the device when placed across an aneurysm or a pseudoaneurysm has not been evaluated.
 
Event Description
It was reported through an article in the journal of vascular surgery titled "complications of endovascular grafts in the treatment of pseudoaneurysms and stenoses in arteriovenous access" that an unknown number of stent grafts was used and that during a 44 month period, several patients presented with complications which included migration, fracture and erosion.The number of devices that were involved is unknown and the deficiencies were not linked to a specific device; therefore, one complaint was conservatively opened to capture the events.Detailed patient outcomes were not reported.
 
Manufacturer Narrative
H10: manufacturing review: a lot history review, a device history record review and complete manufacturing review could not be conducted for the investigation as the lot number is unknown.Investigation summary: the sample wad not returned for evaluation.Three images that were part of the journal article could not clarify the relationship between a specific product and failure mode.Therefore, the investigation is inconclusive for reported issues.A definite root cause for the reported event could not be determined.Labeling review: in reviewing current instructions for use it was found that the instructions for use sufficiently addressed the potential risk.The instructions for use states: 'complications and adverse events associated with use of the fluency plus endovascular stent graft may include the usual complications associated with endovascular stent and stent graft placement and dialysis shunt revisions.These may include the following: allergic reaction, aneurysm, arm or hand edema, bleeding at access site, blood leakage from delivery system (hemostasis), bond joint failures, cellulitis, cerebrovascular accident, congestive heart failure, death, delivery system kinking, detachment of part, face or neck edema, failure to deploy, fever, hematoma, hemoptysis, hemorrhage, high deployment forces, inability to track to target location, inaccurate deployment, incompatibility with accessory devices, infection, insufficient stent graft expansion, no visibility under fluoroscopy, pain, perforation, premature deployment, prolonged bleeding, pseudoaneurysm, rash, reaction to contrast, restenosis requiring reintervention, sepsis, steal syndrome, stent graft embolism, stent graft fracture, stent graft kinking, stent graft migration, stent graft misplacement, thrombotic occlusion, ventricular fibrillation, or vessel rupture.' the instructions for use further states that the safety and effectiveness of the device when placed across an aneurysm or a pseudoaneurysm has not been evaluated.Jill nicole zink, robert netzley, victor erzurum and dennis wright (2012).Complications of endovascular grafts in the treatment of pseudoaneurysms and stenoses in arteriovenous access.Journal of vascular surgery, 57(1):144-8.Doi: 10.1016/j.Jvs.2012.06.087.H11: g1, h6 (patient, method, conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through an article in the journal of vascular surgery titled "complications of endovascular grafts in the treatment of pseudoaneurysms and stenoses in arteriovenous access", during a 44 month period, eleven patients presented with complications which included migration, fracture and erosion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS ENDOVASCULAR STENT GRAFT
Type of Device
ENDOVASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG -9681442
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
1415 w. 3rd street
tempe, AZ 85281
4803032772
MDR Report Key6526122
MDR Text Key73871488
Report Number9681442-2017-00158
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 07/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK FLUENCYPLUS ENDO STNT GRFT
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/30/2017
Initial Date FDA Received04/27/2017
Supplement Dates Manufacturer ReceivedNot provided
06/08/2022
Supplement Dates FDA Received05/31/2017
07/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-